Skip to main content
. 2024 May 30;16:1352681. doi: 10.3389/fnagi.2024.1352681

Figure 3.

Figure 3

Internal validation of the signature. The univariate (A) and multivariate (B) Cox regression analyses demonstrated the independent prognostic value of the signature for Glioma patients (p < 0.001); (C) The time-dependent C-index indicated the accuracy of the signature; (D) The DCA curves emphasized the potential clinical benefits of the signature for Glioma patients.